Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma

Chenxi Cai; Kexin Shu; Wanying Chen; Jiatong Ding; Zishun Guo; Yiping Wei; Wenxiong Zhang

doi:doi:10.18632/aging.204741

← Back

Research Paper Volume 15, Issue 12 pp 5304—5338

Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma

Figure 4. PCA and independent prognostic analysis of the signature. PCA based on all genes (A), all lncRNAs (B), ICD-related lncRNAs (C), and risk signature (D); Univariate (E) and multivariate (F) independent prognostic analysis.